Search for: "COBALT PHARMACEUTICALS"
Results 41 - 60
of 70
Sort by Relevance
|
Sort by Date
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v Eli… [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
23 Mar 2009, 2:21 pm
Reddy's Laboratories, and Cobalt Pharmaceuticals. '639 claims an anti-epileptic drug that UCB markets as Keppra. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
18 Nov 2008, 10:40 pm
., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits for seeking generic approval for Cymbalta tablets. [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
26 Jun 2008, 3:39 am
We reported last month that King Pharmaceuticals filed a citizen petition that could delay final approval of numerous ANDAs for generic versions of Altace (ramipril), which were set to earn final approval on June 7. [read post]
26 May 2008, 9:11 pm
King Pharmaceuticals markets Altace (ramipril), which is indicated for the treatment of high blood pressure. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
9 Apr 2008, 8:49 pm
By Donald Zuhn -- Last week, the Federal Circuit issued an opinion in Ortho-McNeil Pharmaceutical, Inc. v. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
4 Feb 2008, 8:46 am
Lupin argued first that Cobalt forfeited its 180-day exclusivity by entering into a settlement of its patent litigation with King Pharmaceuticals. [read post]
15 Jan 2008, 3:06 am
There were 140 patent cases filed in the Northern District during 2007, an 11% increase from the 126 patent cases filed in 2006. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is… [read post]
28 Nov 2007, 8:11 pm
BRIEFS: Merck brief in support of motion to dismiss Apotex brief in opposition to motion Merck reply brief ADDENDUM:In a separate case, relating to Precose (acarbose), Cobalt Pharmaceuticals recently filed a complaint seeking a declaratory judgment of invalidity or noninfringement with respect to another statutorily-disclaimed patent, U.S. [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
